TAMOXIFEN THERAPY IN RECURRENT EPITHELIAL OVARIAN-CARCINOMA

被引：64

作者：

WEINER, SA

ALBERTS, DS

SURWIT, EA

DAVIS, J

GROSSO, D

机构：

[1] UNIV ARIZONA, DEPT OBSTET & GYNECOL, TUCSON, AZ 85724 USA

[2] UNIV ARIZONA, DEPT PATHOL, TUCSON, AZ 85724 USA

[3] UNIV ARIZONA, ARIZONA CANC CTR, TUCSON, AZ 85724 USA

来源：

GYNECOLOGIC ONCOLOGY | 1987年 / 27卷 / 02期

关键词：

D O I：

10.1016/0090-8258(87)90294-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：208 / 213

页数：6

共 17 条

[1]

BEREK JS, 1983, OBSTET GYNECOL, V61, P189

[2]

BERGQVIST A, 1981, ACTA OBSTET GYN SCAN, P75

[3]

BRENNER DE, 1985, OVARIAN CANCER, P147

[4]

GEISLER HE, 1983, OBSTET GYNECOL, V61, P95

[5] COMPARISON OF CYTOSOL ESTROGEN AND PROGESTIN RECEPTOR STATUS IN MALIGNANT AND BENIGN-TUMORS AND TUMOR-LIKE LESIONS OF HUMAN-OVARY [J].

JANNE, O ;

KAUPPILA, A ;

SYRJALA, P ;

VIHKO, R .

INTERNATIONAL JOURNAL OF CANCER, 1980, 25 (02) :175-179

[6] ESTROGEN AND PROGESTOGEN THERAPY IN ADVANCED OVARIAN-CANCER - PRELIMINARY-REPORT [J].

JOLLES, CJ ;

FREEDMAN, RS ;

JONES, LA .

GYNECOLOGIC ONCOLOGY, 1983, 16 (03) :352-359

[7]

KAUPPILA A, 1983, OBSTET GYNECOL, V61, P320

[8]

LAZO JS, 1984, CANCER RES, V44, P2266

[9] HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED EPITHELIAL OVARIAN-CANCER RESISTANT TO 1ST-LINE OR 2ND-LINE CHEMOTHERAPY [J].

MANGIONI, C ;

FRANCESCHI, S ;

LAVECCHIA, C ;

DINCALCI, M .

GYNECOLOGIC ONCOLOGY, 1981, 12 (03) :314-318

[10]

SCHRADER WY, HORMONE ACTION MOL E

← 1 2 →